• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌醇补充对卵巢反应不良患者 ICSI 结局的影响:一项随机对照试验。

Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial.

机构信息

Department of Obstetrics and Gynecology, Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

IVF Center, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

J Gynecol Obstet Hum Reprod. 2020 May;49(5):101698. doi: 10.1016/j.jogoh.2020.101698. Epub 2020 Feb 1.

DOI:10.1016/j.jogoh.2020.101698
PMID:32018040
Abstract

PURPOSE

This study has evaluated the use of myo-inositol supplementation for improving reproductive outcomes in poor responders undergoing intracytoplasmic sperm injection (ICSI).

METHODS

One hundred and twelve poor responder patients were included in the study and randomly categorized into two groups using a permuted block randomization method. Group A included 56 patients who received myo-inositol (4 g) and folic acid (400 μg) daily from one month before starting the ICSI cycle continuing until the ovulation triggering day. Group B included 56 patients consuming only folic acid (400 μg) daily for the same period. The outcome measures were the number of retrieved oocytes, embryo quality, Ovarian Sensitivity Index (OSI: number of oocytes retrieved/total Gonadotropins units × 1000), fertilization, implantation, and ongoing pregnancy rates.

RESULTS

No significant difference was observed between the two groups regarding the total dose of gonadotropin used, OSI, and the number of total retrieved and mature oocytes. Grad A embryos and fertilization rate were significantly increased in group A. Implantation and pregnancy rates showed statistically insignificant changes.

CONCLUSION

Treatment of poor responders with myo-inositol from one month before starting ICSI cycle continuing until ovulation trigger can improve fertilization rate and embryo quality, and may enhance the cumulative pregnancy rate in poor responders.

摘要

目的

本研究评估了肌醇补充剂在接受胞浆内精子注射(ICSI)的不良反应者中改善生殖结局的应用。

方法

本研究纳入了 112 名不良反应者患者,并采用区组随机化方法将其随机分为两组。A 组 56 例患者在开始 ICSI 周期前一个月开始每日服用肌醇(4 g)和叶酸(400 μg),持续至排卵诱发日。B 组 56 例患者同期仅每日服用叶酸(400 μg)。观察指标包括获卵数、胚胎质量、卵巢敏感指数(OSI:获卵数/总促性腺激素单位×1000)、受精率、着床率和持续妊娠率。

结果

两组在总促性腺激素用量、OSI 和总获卵数及成熟卵数方面无显著差异。A 组的 A 级胚胎和受精率显著增加。着床率和妊娠率无统计学显著变化。

结论

在开始 ICSI 周期前一个月开始用肌醇治疗直至排卵诱发,可以提高受精率和胚胎质量,并可能提高不良反应者的累积妊娠率。

相似文献

1
Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial.肌醇补充对卵巢反应不良患者 ICSI 结局的影响:一项随机对照试验。
J Gynecol Obstet Hum Reprod. 2020 May;49(5):101698. doi: 10.1016/j.jogoh.2020.101698. Epub 2020 Feb 1.
2
Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial.体外受精期间对反应不良者进行肌醇治疗:一项前瞻性对照观察性试验。
J Ovarian Res. 2015 Jun 12;8:37. doi: 10.1186/s13048-015-0167-x.
3
The effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial.肌醇对接受辅助生殖技术的卵巢低反应患者妊娠率的影响:一项随机临床试验。
Reprod Biol Endocrinol. 2021 Apr 23;19(1):61. doi: 10.1186/s12958-021-00741-0.
4
Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.Corifollitropin alfa 序贯高纯度 HMG 与重组 FSH 在年轻卵巢低反应患者中的应用:一项多中心随机对照临床试验。
Hum Reprod. 2017 Nov 1;32(11):2225-2233. doi: 10.1093/humrep/dex296.
5
[Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].国产高纯度尿促卵泡素对控制性卵巢刺激中体外受精-胚胎移植结局的影响
Zhonghua Fu Chan Ke Za Zhi. 2013 Nov;48(11):838-42.
6
Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.使用肌醇和叶酸治疗多囊卵巢综合征女性。新的临床数据及文献综述。
Horm Mol Biol Clin Investig. 2018 Mar 2;34(2):/j/hmbci.2018.34.issue-2/hmbci-2017-0067/hmbci-2017-0067.xml. doi: 10.1515/hmbci-2017-0067.
7
RETRACTED: Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.撤回:肌醇可能改善卵胞浆内单精子注射周期中的卵母细胞质量。一项前瞻性、对照、随机试验。
Fertil Steril. 2009 May;91(5):1750-1754. doi: 10.1016/j.fertnstert.2008.01.088. Epub 2008 May 7.
8
Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?体外受精/卵胞浆内单精子注射的传统卵巢刺激和单胚胎移植。在利用所有新鲜和冷冻胚胎后,我们需要多少个卵母细胞才能使累积活产率最大化?
Hum Reprod. 2016 Feb;31(2):370-6. doi: 10.1093/humrep/dev316. Epub 2016 Jan 2.
9
Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome.在一项随机对照试验中,比较肌醇与褪黑素联合使用和单独使用肌醇对改善多囊卵巢综合征患者体外受精的效果。
Gynecol Endocrinol. 2016;32(1):69-73. doi: 10.3109/09513590.2015.1101444. Epub 2015 Oct 28.
10
[Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].[每个取卵周期的累积活产率:体外受精/卵胞浆内单精子注射临床结局评估]
Zhonghua Fu Chan Ke Za Zhi. 2018 Mar 25;53(3):160-166. doi: 10.3760/cma.j.issn.0529-567X.2018.03.004.

引用本文的文献

1
Oocyte and dietary supplements: a mini review.卵母细胞与膳食补充剂:一篇小型综述
Front Cell Dev Biol. 2025 Jun 26;13:1619758. doi: 10.3389/fcell.2025.1619758. eCollection 2025.
2
The role of diet and food supplements in infertility management in the Eastern Mediterranean Region: A narrative review.饮食与膳食补充剂在东地中海地区不孕症管理中的作用:一项叙述性综述。
Int J Reprod Biomed. 2025 Mar 21;23(1):1-16. doi: 10.18502/ijrm.v23i1.18188. eCollection 2025 Jan.
3
Effect of myo-inositol supplementation in mixed ovarian response IVF cohort: a systematic review and meta-analysis.
补充肌醇对混合卵巢反应的体外受精队列的影响:一项系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2025 Mar 21;16:1520362. doi: 10.3389/fendo.2025.1520362. eCollection 2025.
4
A retrospective study "myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.".一项回顾性研究“肌醇是一种用于非多囊卵巢综合征患者控制性卵巢刺激的节约成本策略”。
Health Econ Rev. 2025 Mar 15;15(1):20. doi: 10.1186/s13561-025-00609-8.
5
The Clinical Use of Myo-Inositol in IVF-ET: A Position Statement from the Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), the Polish Society of Andrology, and the International Scientific Association for the Support and Development of Medical Technologies.肌醇在体外受精-胚胎移植中的临床应用:来自基础与临床研究及多囊卵巢综合征肌醇专家组(EGOI-PCOS)、波兰男科学会和国际医疗技术支持与发展科学协会的立场声明
J Clin Med. 2025 Jan 16;14(2):558. doi: 10.3390/jcm14020558.
6
Improvement in biochemical manifestations of the serum and follicular fluid and ICSI outcomes in PCOS patients with myo-inositol administration: prospective randomized research.多囊卵巢综合征患者服用肌醇后血清和卵泡液生化指标及卵胞浆内单精子注射结局的改善:前瞻性随机研究
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun;398(6):7187-7198. doi: 10.1007/s00210-024-03745-w. Epub 2024 Dec 24.
7
Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis.抗氧化剂与卵巢衰老女性的生育能力:系统评价和荟萃分析。
Adv Nutr. 2024 Aug;15(8):100273. doi: 10.1016/j.advnut.2024.100273. Epub 2024 Jul 15.
8
The Role of One-Carbon Metabolism and Methyl Donors in Medically Assisted Reproduction: A Narrative Review of the Literature.一碳代谢和甲基供体在医学辅助生殖中的作用:文献综述。
Int J Mol Sci. 2024 May 2;25(9):4977. doi: 10.3390/ijms25094977.
9
Researching the Phenomenon of Poor Ovarian Responders and Management Strategies in IVF: A Narrative Review.探讨 IVF 中卵巢反应不良现象及管理策略:一项叙述性综述。
Acta Med Acad. 2022 Aug;51(2):108-122. doi: 10.5644/ama2006-124.379.
10
Melatonin and Myo-Inositol: Supporting Reproduction from the Oocyte to Birth.褪黑素和肌醇:从卵子到出生支持生殖。
Int J Mol Sci. 2021 Aug 5;22(16):8433. doi: 10.3390/ijms22168433.